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ABSTRACT 1 
Background: The concept of Dietary Folate Equivalents (DFE) in the US recognizes the 2 
differences in bioavailability between natural food folates and the synthetic vitamin, folic 3 
acid.  However, many published reports on folate bioavailability are problematic as a result of 4 
a number of confounding factors. 5 
Objective: The aim was to compare the bioavailability of food folates with folic acid under 6 
controlled conditions.  To broadly represent the extent to which natural folates are conjugated 7 
in foods, we used two natural sources of folate, spinach and yeast, in which folates are present 8 
as 50% and100% polyglutamyl folate, respectively. 9 
Design: 96 male subjects were randomized on the basis of their screening plasma 10 
homocysteine (tHcy) to one of four treatment groups for an intervention period of 30-days. 11 
Each subject received (daily under supervision) either a folate depleted “carrier” meal or a 12 
drink plus: a) placebo tablet; b) 200µg folic acid in a tablet; c) 200µg natural folate provided 13 
as spinach; or d) 200µg natural folate provided as yeast. 14 
Results:  Among those who completed the intervention, responses (increase in serum folate, 15 
lowering of tHcy) compared to placebo (n=18) were significant in the folic acid group (n=18), 16 
but not in the yeast folate (n=19) or the spinach folate (n=18) groups. Both natural sources of 17 
folate were significantly less bioavailable than folic acid. Overall estimations of folate 18 
bioavailability were found to be between 30% (spinach) and 59% (yeast) relative to folic acid.  19 
Conclusion:  Relative bioavailability estimates were consistent with those from the metabolic 20 
study which was used as a basis to derive the US DFE value.   21 
 22 
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INTRODUCTION 1 
Folate is attracting major interest in recent years as having an established role in the 2 
prevention of neural tube defects (NTD, 1,2) and possible preventive roles against 3 
cardiovascular disease (3), certain cancers (4) and neuro-psychiatric conditions (5).  For the 4 
prevention of NTD, official bodies worldwide recommend women to take an additional 400-5 
µg/d folate before conception and in early pregnancy. However, the achievement of such 6 
recommendations is problematic. Although folic acid supplements are very effective in 7 
optimizing folate status in women who receive them (6), they do not offer an effective 8 
strategy for the primary prevention of NTD because of poor compliance (7).  Therefore, in 9 
recent years, mandatory fortification of grain products with folic acid has been introduced in 10 
the United States (8) and elsewhere (9). Despite impressive decreases in the incidence of 11 
NTD since the introduction of these new policies (10,11), fortification remains controversial.  12 
It is untargeted and therefore, delivering the required nutrient levels to the at risk group, 13 
inevitably results in a proportion of the general population being exposed to high levels.  Of 14 
greatest concern is the potential for high intakes of folic acid to mask the anemia of vitamin 15 
B12 deficiency in elderly people, thereby allowing the concomitant irreversible nerve 16 
degeneration to go undetected (12). The third approach to optimize folate status, which does 17 
not have such health concerns, is by increased consumption of foods naturally rich in folate. 18 
However, the effectiveness of this approach has been found to be somewhat limited 19 
(13,14,15), a finding generally attributed to the poor bioavailability of natural food folates 20 
compared with the synthetic vitamin, folic acid. 21 
 22 
Depending primarily on the methodological approach used, previous human studies have 23 
estimated the bioavailability of food folates relative to folic acid to range anywhere between 24 
10% and 98% (16-21). The uncertainty regarding folate bioavailability (15) is of particular 25 
 4
concern for countries without folic acid fortification (including some which do not even 1 
permit it on a voluntary basis)(22), and therefore, a high dependency on natural food folates 2 
as a means to optimize status.  In addition, although mandatory folic acid fortification in the 3 
US means that there is relatively less reliance placed on natural folate sources, US dietary 4 
recommendations are now based on the greater bioavailability of folic acid added to food 5 
compared with natural food folates, with the recent introduction of Dietary Folate Equivalents 6 
(DFE)(23). The estimated DFE conversion factor of 1.7 is largely based on one metabolic 7 
study in non-pregnant women which estimated the bioavailability of food folates to be no 8 
more than 50% that of folic acid (19), and other evidence showing that folic acid added to 9 
food had about 85% the bioavailability of free folic acid (24). 10 
 11 
The aim of this study was to compare the bioavailability of food folates with folic acid under 12 
controlled conditions.  The approach was to administer natural sources of folate under 13 
supervision at a dose (of pre-determined folate content) within the physiological range, but 14 
sufficiently concentrated so as to elicit serum folate and plasma homocysteine (tHcy) 15 
responses, for comparison with an equivalent dose of folic acid.  In order to broadly represent 16 
the extent to which natural folates are conjugated in foods, we used two folate-rich sources, 17 
spinach and yeast, in which folates are present as 50% and 100% polyglutamyl folate, 18 
respectively. 19 
 20 
 21 
 22 
 23 
 24 
 25 
 5
SUBJECTS AND METHODS 1 
Subject recruitment and screening 2 
The Research Ethical Committee of the University of Ulster granted ethical approval, and 3 
subjects gave written informed consent at the time of recruitment to the study. Healthy men, 4 
aged 18-45 years were recruited between December 2000 and September 2001 from the staff 5 
and student population at the University of Ulster, the Causeway Health and Social Services 6 
Trust, Coleraine; and the FG Wilson engineering firm, Belfast. All potential subjects were 7 
interviewed, using a short medical questionnaire about their general health, medication and 8 
supplement use, to identify those meeting the following inclusion criteria: no history of 9 
gastrointestinal, vascular, hepatic, renal disease or hematological disorders, not taking B 10 
vitamin supplements nor consuming folic acid-fortified foods, not taking drugs known to 11 
interfere with folate metabolism.  In addition, a blood sample was collected in order to screen 12 
volunteers for identification of the 677C→T (thermolabile) variant of the 13 
methylenetetrahydrofolate reductase (MTHFR) gene, and to determine plasma homocysteine 14 
(tHcy) concentrations. Individuals who were found to be homozygous for the 677C→T 15 
mutation (i.e. TT genotype) were excluded from the study.  16 
 17 
Intervention  18 
Suitable subjects were randomized on the basis of their screening tHcy levels to one of four 19 
treatment groups.  The subjects received either a folate depleted “carrier” meal or a drink 20 
plus: a) placebo tablet; b) 200µg folic acid in a tablet; c) 200µg folate provided as spinach; or 21 
d) 200µg folate provided as yeast.   22 
 23 
 6
Pre-intervention treatment 1 
For a 4-week run-in period prior to commencement of the folate intervention described below, 2 
all subjects (irrespective of the treatment group) were administered daily with oral 3 
supplements of vitamin B6 (1.6mg/d) and vitamin B12 (1.5µg/d), doses equivalent to UK 4 
Reference Nutrient Intake values (25).  In order to monitor compliance, subjects were 5 
provided with these supplements on a weekly basis in a 7-day pill organizer box (Carepac, 6 
Farringdon, UK), and asked to return the box at each visit; any missed doses were recorded.  7 
This treatment was continued for the duration of the entire study, i.e. until completion of the 8 
folate intervention.  9 
 10 
Folate intervention  11 
The folate intervention was conducted as a placebo controlled, blind study, which was carried 12 
out over a 6-week period, during which treatments were administered 5 days per week (i.e. in 13 
total, a 30 day folate intervention). In order to ensure compliance, subjects were supervised 14 
while taking the treatments on a daily basis.   Each of the four treatments was administered in 15 
one of two ways, either as a meal (with other food present) or as a drink (with no other food 16 
present).   17 
 18 
Administration of treatments as a meal 19 
Each morning a “carrier meal” was freshly prepared by the catering staff at the School of 20 
Hotel, Leisure and Tourism, University of Ulster, Portrush, Northern Ireland, under the 21 
supervision of two colleagues (MHF and one other author, MAS) from the Northern Ireland 22 
Center for Diet and Health (NICHE), University of Ulster, Coleraine. A total of 4 carrier 23 
meals were devised and rotated on a weekly menu cycle. Ingredients selected for use in the 24 
carrier meals were of low folate content, according to the British Food Composition Tables 25 
 7
(26). The ingredients (for full list see Appendix) were thrice boiled in order to reduce the 1 
water-soluble micronutrient content (i.e. placed in cold water and taken to boiling temperature 2 
for a minimum of one minute, the water was removed and replaced with fresh cold water; this 3 
was carried out three times before the food was finally cooked).  For each of the carrier meals, 4 
a duplicate meal was retained and stored for later analysis of total folate content, this was 5 
repeated on two separate occasions during the folate intervention. 6 
 7 
Volunteers attended our catering center daily between 12 noon and 2pm to receive their 8 
intervention treatments under supervision. The carrier meal was provided as a lunch to all 9 
volunteers irrespective of their treatment group allocation.  Each subject received either the 10 
carrier meal alone (placebo treatment) or the carrier meal enriched to provide 200µg of 11 
natural folate provided from one of two natural folate sources, either lyophilized spinach 12 
(7.8g; Kanegrade, Stevenage UK) or lyophilized yeast (4.1g; Allinson, Castleford UK), with 13 
poly- to monoglutamate ratios of approximately 50:50 and 100:0, respectively. The natural 14 
folate source was added to the carrier meal after the meal was fully cooked, and immediately 15 
before starting serving, the meal was then maintained under heat lights while being served. In 16 
addition, after consuming half of the meal, all subjects received a pill, either placebo or 200µg 17 
synthetic folic acid. Subjects drank only water and were not permitted to use additional sauces 18 
or seasoning with the meal. Volunteers were instructed to follow their usual dietary pattern 19 
for all other meals and snacks consumed during the intervention period. 20 
 21 
Administration of treatments as a drink 22 
Volunteers received either a placebo drink or a drink that provided 200µg of natural folate in 23 
a disposable plastic cup at their place of work mid morning (10-11am) under the supervision 24 
of two colleagues (MHF and NCA). The drinks were prepared freshly before each 25 
 8
administration as follows: 7.8g lyophilized spinach or 4.1g lyophilized yeast (the equivalent 1 
of 200µg total folate) were added to 20 ml water. The drinks were mixed vigorously; 50ml of 2 
sugar free lemonade was added and again mixed. The placebo drink consisted of 20ml of 3 
water and 50ml sugar free lemonade, with no other ingredient. All drinks were prepared at the 4 
same time each morning and consumed within 2 hours. Volunteers also received a pill, either 5 
placebo or 200µg synthetic folic acid, which was taken after consuming the first half of the 6 
drink. Any residue remaining in the cup was rinsed with a small volume of lemonade, which 7 
the subject was required to drink in order to ensure the ingestion of the entire treatment dose. 8 
Apart from this drink, subjects were instructed to follow their usual dietary pattern for the 9 
duration of the study. 10 
 11 
Laboratory methods  12 
Blood sampling and analysis 13 
Blood samples were collected following an overnight fast (min 12 hours) at screening, pre-14 
intervention with folate and post-intervention with folate. For each time point (other than 15 
screening), two blood samples were collected 2-4 days apart (shown to be the optimal time 16 
interval between repeated blood sampling for measurement of tHcy) (27).  A total of 22ml of 17 
blood was collected from each subject into EDTA-coated pre-evacuated blood tubes for full 18 
blood count, whole blood folate, plasma pyridoxal- 5’phosphate (PLP), and tHcy analysis, or 19 
into a Vacuette Serum Separator tube (Greiner Labortechnik, Germany) for analysis of serum 20 
folate and serum B12. Samples for PLP and tHcy analysis were wrapped in foil and placed on 21 
ice immediately after collection.  Sample preparation and fractionation were performed within 22 
0.5 to 2.5 h of the time of sampling as described in detail elsewhere (28) and fractions were 23 
stored at –70OC for batch analysis at the end of the study and at –20 OC for extraction of 24 
DNA. 25 
 9
Full blood counts were carried out on whole blood with an automated Coulter Counter 1 
(Causeway Health and Social Services Trust Laboratories, Coleraine, Northern Ireland).  2 
Plasma tHcy was measured by immunoassay (29). Red blood cell folate (30), serum folate 3 
(30), and serum vitamin B-12 (31) were measured by microbiological assay. Plasma PLP was 4 
measured by reversed-phase HPLC with fluorescence detection (32).   For all assays, samples 5 
were analyzed blind, in duplicate and within 6 months of sampling. Quality control was 6 
provided by repeated analysis of stored batches of pooled plasma (for tHcy and PLP), serum 7 
(for folate and vitamin B-12), and red blood cell lysates (for folate), covering a wide range of 8 
values in each case.  9 
 10 
From screening samples, DNA was extracted from frozen whole blood by incubating with 11 
proteinase K (Gibco Life Technologies, Paisley, UK) as described in detail by Kawasaki (33), 12 
or using the QIAamp DNA Blood Mini Kit (UK QIAGEN Ltd., Crawley, West Sussex). The 13 
MTHFR 677C T mutation (i.e. TT genotype) was identified by polymerase chain reaction  14 
(PCR) amplification followed by HinF1 restriction digestion  (Gibco Life Technologies, 15 
Paisley, UK), as previously described (34).  16 
 17 
Natural folate analysis  18 
The total folate content of the yeast, spinach and “carrier meals” was measured by 19 
microbiological assay with Lactobacillus casei NCIB 10463 (30) following thermal extraction 20 
and trienzyme (α-amylase, protease and conjugase) treatment according to the procedure of 21 
Tamura (1998)  (35). The calibration of the assay was performed using folic acid (Sigma 22 
Chemical Co, Poole Dorset) as a standard. Under the conditions of the assay in our laboratory 23 
(pH 6.7 of the assay medium) L. casei shows equivalent responses to the main folate 24 
derivatives found in foods. Folate assays were performed both at the start and at the end of the 25 
 10
intervention period (in each case, triplicate measurements on two separate occasions two days 1 
apart). The coefficient of interassay variation in folate content of quality control samples was 2 
5.5% (n=48). The folate polyglutamate content in yeast and spinach was determined as the 3 
mean difference in total folate content of samples treated with and without folate conjugase.  4 
 5 
Dietary assessment 6 
Dietary intake was recorded during the intervention period by a self-administered 4-day food 7 
diary (2-week days and 2-weekend days). Food intake data were analyzed for energy and 8 
nutrient intakes using the dietary analysis program WISP (WISP for Windows version 1.28, 9 
Tinuviel Software, Warrington, UK).  10 
 11 
Statistical analysis 12 
The Statistical Package for the Social Sciences (SPSS version 11; SPSS Inc., Chicago, IL, 13 
USA) was used to compare the effects of intervention  among the treatment groups using 14 
ANCOVA. The pre-treatment value was used as a covariate; pre and post treatment values 15 
were log-transformed. Treatment comparisons were made using Tukey’s test multiple 16 
comparisons procedure, values <0.05 were considered significant. 17 
 18 
In order to represent the response to intervention of food folates relative to that of folic acid, 19 
estimations of relative bioavailability (%) were calculated as follows: 20 
pf
pt
xx
xx
RB
−
−
=  x 100 21 
where RB is the relative bioavailability, tx  is the treatment group (yeast or spinach) mean 22 
response, px  that in the placebo group and fx that in the folic acid group. 95% confidence 23 
intervals were calculated by bootstrapping and truncated at zero  (36). 24 
 25 
 11
RESULTS 1 
Baseline data 2 
Of 127 subjects initially recruited and screened, 96 satisfied the inclusion criteria and 3 
proceeded to intervention (24 to each of four treatment groups), of which 74 subjects 4 
completed the study Figure 1.  Subjects either withdrew from the study voluntarily or were 5 
withdrawn if their attendance (compliance) was less than 95% (in practice this meant failure 6 
to attend on more than one occasion over the 30 d intervention).  Subjects who successfully 7 
completed the intervention had an attendance rate of 100%. The baseline characteristics of 8 
this cohort expressed as median and 25th-75th quartiles are presented in Table 1.  No subject 9 
was found to have deficient status of folate (serum or red cell folate) or related B vitamins 10 
(plasma PLP or serum B12) prior to the intervention period.  11 
 12 
Following randomization of subjects by tHcy concentrations at screening, there were no 13 
significant differences between groups in tHcy, serum folate or red cell folate, either before or 14 
after the 4-week run-in period with physiological doses of vitamins B6 and B12 (independent 15 
t- test; results not shown). However, as expected, significant increases (before vs. after 4-16 
week run in period, paired t-test) in both PLP (73.4nmol/L vs. 108nmol/L; p< 0.001) and 17 
serum B12  (297pmol/L vs. 325pmol/L; p< 0.05) were observed. Although treatment with 18 
vitamins B6 and B12 continued for a further 6-weeks (i.e. throughout folate intervention) no 19 
further increase in either parameter was observed (i.e. week 4 vs. week 10). 20 
 21 
Natural folate analysis 22 
Analysis of the carrier meals (two separate measurements for each of four meals, each 23 
assayed in triplicate) for total folate content showed a mean folate value of 44.89 ± 16.5 24 
µg/meal (Appendix). 25 
 12
The total folate content of yeast and spinach, analyzed both at the start and at the end of 1 
intervention for each folate source (in each case, triplicate measurements on two separate 2 
occasions two days apart) showed that the quantity of natural folate sources required to 3 
provide 200 µg folate corresponded to mean weights of 4.1 g (4.16g ± 0.44 at the start; 3.78g 4 
± 0.46 at the end of intervention) of lyophilized yeast, and 7.8 g (7.77g   ± 0.94; 7.54g ± 0.86) 5 
of lyophilized spinach.  The ratio of poly- to mono-glutamate folate in spinach and yeast was 6 
found to be 50:50 and 100:0, respectively, whether this was measured at the start or at the end 7 
of intervention.  8 
 9 
Intervention 10 
In order to determine the relative effects of intervention with the various treatments, the 11 
response (post-intervention value minus the pre-intervention value) of each treatment was 12 
compared among the four treatment groups (Table 2).  The folic acid response (both tHcy and 13 
serum folate) was significantly different from placebo, spinach and yeast, no other significant 14 
differences were observed. The overall bioavailability of these representative natural folate 15 
sources relative to folic acid (and adjusted for placebo effect) was estimated to be 30% (tHcy 16 
response 23%; serum folate response 36%) for spinach, and 59% (56%; 62%) for yeast.  Thus 17 
the average bioavailability of these representative food folate sources was estimated to be 18 
45%. 19 
 20 
Analysis of food intake data for total energy and total folate are presented in Table 3, and 21 
showed no significant differences among the four treatment groups. 22 
 23 
 24 
 25 
 13
Percentage responses to intervention (the post-intervention value minus the pre-intervention 1 
value expressed as a percentage of the pre-intervention value) for both serum folate and tHcy 2 
are shown in Figure 2. The percentage response of both parameters to folic acid was 3 
significantly different from the response to placebo, spinach and yeast, no other significant 4 
differences were observed. 5 
 6 
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DISCUSSION 1 
In devising the DFE conversion factor in the United States, experts drew heavily on one 2 
metabolic study in women conducted several years ago which estimated folate bioavailability 3 
from a mixed diet to be no more than 50% relative to that of folic acid (19). Reported 4 
estimates of food folate bioavailability since then are highly variable.  Representative natural 5 
folate sources in the current study were found to be significantly less bioavailable than folic 6 
acid, with estimated relative bioavailability consistent with the report of Sauberlich et al. 7 
based on a mixed diet (19). 8 
 9 
The bioavailability of folates from various foods is considered to be dependent on the content 10 
of monoglutamyl and polyglutamyl folates, and the presence of components that can inhibit 11 
both intestinal folate deconjugation and specific transport processes of folate (17). Dietary 12 
folates  (excluding fortified foods) are comprised of about one third monoglutamate (derived 13 
mainly from bread and meat) and two-thirds polyglutamate (derived mainly from vegetables) 14 
(37).  In the current study, we used two folate-rich sources, spinach and yeast, not because we 15 
wished to specifically study these foods as sources of folate per se, but rather to broadly 16 
represent the extent to which natural folates are conjugated in foods.  Thus while yeast is not 17 
an important dietary source of folate, its inclusion in our study enabled us to compare a folate 18 
source which was entirely in the polyglutamate form with another which had a much lower 19 
content (50%) of polyglutamyl folate.  Although we showed no significant difference in the 20 
responses between these two food folate sources, the trend seen was consistently towards 21 
higher bioavailability (whether based on serum folate or tHcy responses) of folate from yeast 22 
compared to spinach.  Given that folate in yeast is all in the polyglutamate form, and is even 23 
reported to contain potent inhibitors of certain conjugases (38), our results provide no 24 
evidence to support the view that the extent of glutamation is a limiting factor in the 25 
 15
bioavailability of folates from natural sources.  Such observations are in good agreement with 1 
previous findings (39) from studies using exogenous deuterium-labeled monoglutamyl and 2 
polyglutamyl folates added to various foods, which showed equivalent bioavailability for the 3 
two folate forms. Results from the current study and the aforementioned study (39), are 4 
consistent with earlier observations (40) indicting that the activity of human jejunal brush 5 
border conjugase exceeds that needed for hydrolysis of polyglutamyl folates within the range 6 
of dietary intake and, therefore, was not rate limiting in the absorption process.   7 
 8 
Apart from the activity of the conjugase enzyme, factors considered to influence the 9 
bioavailability of ingested folates include the presence or absence of other components in the 10 
diet or in the intestinal milieu that may inhibit or enhance absorption (41).  Pfeiffer et al. (24) 11 
for example reported a small reduction in absorption of  [13C5] folic acid when administered 12 
after a light breakfast meal compared to its administration without food.  Although in the 13 
current study all four treatments were administered in one of two ways, either in a drink with 14 
no other food present or as part of a meal, a sub-analysis of the overall results comparing the 15 
responses according to the route of administration was not possible because of insufficient 16 
subject numbers completing the meal arm (across the four treatment groups). Further studies 17 
are clearly required to address this issue.   18 
 19 
Reported estimates of relative bioavailability of food folates show great variation, ranging 20 
from 10% to 98% (16-21), depending on the methodological approach and response index 21 
used. The interpretation of bioavailability studies in free-living subjects involving the 22 
provision of folate rich foods may be particularly problematic as a result of a number of 23 
confounding effects.  The current study, in which all treatments were administered daily 24 
under supervision and were of predetermined folate content, allowed a number of potential 25 
 16
confounding effects to be overcome, including poor subject compliance and displacement of 1 
the usual dietary folate intake with intervention foods (13).  In addition, all of the 2 
administered natural folate (provided as spinach or yeast) came from the same batch and was 3 
not subjected to cooking or further processing prior to ingestion, thereby eliminating the 4 
confounding effect of folate losses during cooking, which may be considerable in the case of 5 
green vegetables (42).  Although stable-isotopic studies overcome these potential 6 
confounders, their applicability is limited somewhat in that in order to improve the precision 7 
of short-term studies, pre-saturation of tissues with folate is recommended, thereby creating a 8 
non-physiological condition (24). The bioavailability of natural folate sources estimated in the 9 
current study is much lower than that from a previous long-term intervention study (21) which 10 
estimated the bioavailability of food folates relative to folic acid to be between 60 and 98% 11 
(depending on the endpoint used).  The strength of the latter study (21) lies in its attempt to 12 
assess folate bioavailability from a mixed diet rather than from individual foods. The 13 
unexpected findings, however, may be the result of one or more of the following confounding 14 
factors.  First, the response of folic acid may have been underestimated as a result of 15 
administering 500µg folic acid every-other-day, on the assumption that it would be equivalent 16 
to 250µg daily. Higher intakes of folic acid (i.e. doses in excess of 266µg) have been shown 17 
to exceed the metabolic capacity of the intestinal mucosa, resulting in the appearance of 18 
unreduced folic acid in the circulation (43), the uptake of which may not be equivalent to the 19 
reduced vitamin.  A second limitation of the study is that the natural food folate and folic acid 20 
groups did not receive comparable doses of the vitamin (350µg of natural folate daily versus 21 
500µg of synthetic folic acid every-other-day), although this clearly was not intended in the 22 
study design. There was some attempt to correct for the different doses at the analysis stage. 23 
Corrected values, however, may not necessarily represent relative food folate bioavailability 24 
 17
to the same degree as a study, such as the current one, in which equivalent doses were 1 
administered daily throughout the intervention period.  2 
 3 
We used two response indices to assess folate bioavailability, serum folate and a functional 4 
biomarker of folate status, plasma tHcy, previously shown by us to be a reliable index which 5 
responds to low dose folic acid in a dose dependent manner (44).  Our estimations of 6 
bioavailability of natural folate (relative to folic acid) are similar whether they are based on 7 
tHcy or serum folate responses (yeast folate 56% vs 62%; spinach folate 23% vs 36%, 8 
respectively). Thus, our results show good internal robustness in the estimation of folate 9 
bioavailability from natural sources.  However, the use of tHcy responses in the determination 10 
of relative folate bioavailability required the inclusion in our study design of a 4-week pre-11 
treatment period with physiological doses of vitamin B12 and B6. This was necessary in order 12 
to ensure that any homocysteine-lowering owing to the presence of these vitamins in foods 13 
was corrected prior to the folate intervention.  Red cell folate responses were not used in the 14 
estimation of folate bioavailability because we considered that the duration of the intervention 15 
(30 d) was insufficient to observe a complete turnover of the red cell folate population (i.e. 16 
120 days), and therefore fully reflect the effect of the red cell folate response.  17 
 18 
In conclusion, the bioavailability of natural folate is now important given that the alternatives 19 
only offer partial solutions for addressing sub-optimal folate status in the general population, 20 
either because of limited compliance (in the case of folic acid supplementation) or safety 21 
concerns (in the case of fortification).  By comparing the bioavailability of representative 22 
natural folate sources with folic acid, we estimate the relative bioavailability of natural folate 23 
to be approximately 45%. In addition to losses of natural folates due to their incomplete 24 
bioavailability shown here, in practice losses prior to ingestion may also decrease the amount 25 
 18
of available folate from natural sources, particularly in the case of green vegetables (42).  1 
Finally, the estimations of relative bioavailability in the current study are consistent with 2 
those estimated in the metabolic study by Sauberlich et al. (19) that was the cornerstone of the 3 
recently derived US DFE value.   4 
 5 
 6 
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Treatment
Group
Mode of
Administration
127 Subjects Screened
Completed
n=7
Meal
n=12
Completed
n=11
Drink
n=12
Folic acid group
n=24
Completed
n=6
Meal
n=12
Completed
n=13
(+1 meal)
Drink
n=12
Placebo group
n=24
Completed
n=6
Meal
n=12
Completed
n=12
Drink
n=12
Spinach folate group
n=24
Completed
n=7
Meal
n=12
Completed
n=12
Drink
n=12
Yeast folate group
n=24
Fulfilled selection criteria
n=96
Table 1: General characteristics, dietary status and laboratory nutrient status of 
subjects at screening*. 
 
Parameter Reference 
range 
Median  25th –75th quartile 
 
Age (years)     
Body Mass Index (kg/m2)   
Energy intake (MJ/d)    
Folate intake (µg/d)    
B12 intake (µg/d)    
B6 intake (mg/d)    
Riboflavin intake (mg/d)   
Plasma Homocysteine (µmol/L)  
Serum Folate (nmol/L)   
Red Cell Folate (ng/mL) 
Serum B12 (pg/mL) 
Plasma PLP5  (nmol/L) 
 
18-45 years 
18.5-24.91 
- 
2002  
1.52 
1.42 
1.32 
5-153 
6.1-454 
150-10004 
150-10004 
>305 
 
31.0 
26.3 
8.0 
183 
2.9 
1.9 
1.3 
10.5 
16.67 
385 
415 
67.7 
 
23.3 – 38.5 
23.5 – 28.8 
7.0 – 11.0 
140 - 235 
2.0 - 4.4 
1.8 - 2.4 
1.0 - 1.5 
8.9 - 12.3 
12.3 – 22.1 
303 - 485 
291 - 554 
48- 89 
*median and 25th – 75th quartile. 
n=74. 
1Normal range of body mass index (BMI) for healthy males. 
2Reference nutrient intake in the United Kingdom for males between the ages of 19-50y (26). 
3Reference range for normal homocysteine concentration (44). 
4Laboratory reference ranges for normal serum and red cell folate concentrations; Vitamin 
Research Laboratory, Trinity College Dublin.  
5PLP: Pyridoxal 5’- phosphate, vitamin B6 (45). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Plasma total homocysteine (tHcy) and serum folate responses to a 30-day 
intervention with 200µg natural folate/folic acid. 
 
 
 
Pre-
intervention 
Post-
intervention 
Response1 Relative 
Bioavailability2 
Plasma homocysteine 
(µmol/L) 
    
Placebo (n=18) 11.6 ±3.7 11.8 ± 3.3 0.2 ± 1.2b  
Folic Acid (n= 18) 11.5 ± 3.0 10.1 ± 1.9 -1.4± 2.1a  
Spinach Folate (n=18) 12.1 ± 2.9 11.7 ± 2.5 -0.4 ± 1.1b 23% 
Yeast Folate  (n=19) 11.9 ± 3.2 11.2 ± 2.7 -0.7± 0.9b 56 % 
 
Serum folate (nmol/L)     
Placebo (n=18) 15.9 ± 9.4 15.4 ± 8.4 -0.4 ± 4.2b  
Folic Acid (n= 18) 17.2 ± 11.9 21.6 ± 13.1 4.4 ± 4.8a  
Spinach Folate  (n=18) 13.5 ± 5.1 15.2 ± 6.5 1.8 ± 4.0b 36% 
Yeast Folate  (n=19) 15.0 ± 7.2 17.6 ± 5.69 2.6 ± 3.5b 62% 
 
Values are mean ± standard deviation and represent double (2-4 days apart), fasting samples. 
Responses were compared using Analysis of Covariance (ANCOVA) on log-transformed data 
(response = log post/pre).  Means not sharing a common superscript letter are significantly 
different  (p< 0.05) based on Tukey’s test for multiple comparisons. 
1 Response refers to the post-intervention value minus pre-intervention value. 
2Relative bioavailability refers to the response of yeast or spinach relative to the response of 
folic acid and corrected for the placebo response, for calculation see text. (95% CI calculated 
by bootstrapping and truncated at zero%:  spinach: tHcy, 0-80%; serum folate, 0-90%); yeast: 
tHcy, 20-170%; serum folate, 20-170%), 
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 Table 3: Dietary total folate and total energy intake1 in all treatment groups. 
 
Treatment Group Folic Acid Placebo Spinach Yeast 
Total Dietary Folate (µg/d) 2 202 ± 84 186 ± 70 184 ± 70 211 ± 86 
Total Energy (MJ/d) 9.11± 2.19 8.29 ± 2.17 8.70 ± 2.47 9.72 ± 2.37 
  
Values are mean ± standard deviation.  
No significant differences were observed for total folate (p = 0.31) or total energy (p = 
0.49) intakes among the treatment groups, one-way ANOVA. 
 
1Dietary intakes were measured mid-intervention. 
2Folate intake values do not include the contribution from the folate treatments administered 
daily (200µg/d folic acid/ folate). 
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Appendix 1. General cooking instructions and ingredients used to prepare “carrier” 
meals  (serve 4).  
General Instructions for all 
meals to be prepared: 
All vegetables, meat, pasta 
and rice used were thrice 
boiled. 
Dry ingredients such as 
herbs, spices, stock cubes 
(chicken & beef) salt & 
pepper and other ingredients 
used for flavourings such as 
Tabasco, Worchester sauce, 
gravy browning (black jack), 
honey, brown sugar, mustard 
(dry) and fresh garlic were 
not required to be pre-boiled. 
Bisto, soy sauce and canned 
tomatoes were not used. 
Chicken Duxelle (Total 
folate: 63.2 ± 22.6µg/meal) 
Onions- 100g                             
Mushrooms- 400g 
Chicken- 600 g 
Margarine- 25 g 
Eggs- 2 
Milk-90ml 
Breadcrumbs-100g 
Nutmeg-10g  
Dry sherry-150ml 
Water- 360ml 
Demiglaze-70.35g 
Turnips-740g 
Carrotts-438g 
Salt-3g 
Pepper-1.5g 
Pasta Bake (Total folate: 
38.1± 15.4µg/meal) 
Pasta-200g 
Mushrooms-132g 
Smoked bacon (without fat)-
147g 
Peppers (red)-124g 
Margarine-50g 
Flour (plain white)-50g 
Milk-720ml 
Salt-1.5g 
Cheese-371g 
Gloves-2 
Bay leaf-1 
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Following the thrice-boiling 
ingredients used in the sauce 
were pan fried in oil 
(groundnut or olive) and 
garlic. 
Spices & herbs and 
flavourings were added to 
the pan and cooked together 
with the meat and vegetables 
for a few minutes and finally 
the stock (wine/sherry etc.) 
was added. 
Thai Green Curry (Total 
folate: 38.6 ± 5.3µg/meal) 
Chicken- 655g 
Olive oil- 35g 
Chicken stock- 250ml (or half 
chicken stock cube) 
Garlic -6g 
Root ginger-4 g 
Coconut milk-115ml 
Green curry paste-5g 
Coriander leaves-10.5g 
Lime juice -9.5g 
Salt- 3g 
Rice-200g 
Black pepper-1g 
Chicken and Gammon Pie 
(Total folate: 39.5 ± 
15.2µg/meal) 
Chicken breast-375g 
Smoked gammon-350g 
Mushrooms-100g 
Margarine-50g 
Flour-50g 
Cream-200ml 
1 chicken stock cube 
Water-750ml 
Carrots-480g 
Parsnips-300g 
Pastry (frozen) 
 
Folate content of the carrier meals is expressed as mean ± standard deviation. 
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Figure 1: Subject group allocation and rates of completion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1one subject, who had been assigned to receive the placebo treatment as a meal, 
reported on day one that he would be unable to attend the catering centre at the 
specified time each day. This subject agreed to be reassigned to receive the treatment 
as a drink, to be administered daily (mid-morning) at his place of work.  
 
 
 
 
 
Figure 2: Comparison of percentage response of plasma homocysteine and serum 
folate to a 30-day intervention with 200µg folate as either synthetic folic acid or 
natural folate source1. 
 
 
 
Values are mean  ± SEM and represent double (2-4 days apart) fasting samples. 
Percentage responses (homocysteine and serum folate) among the four groups were 
compared using log-transformed data for normalization purposes.  Means not sharing 
a common letter are significantly different (p< 0.05) based on Tukey’s test for 
multiple comparisons. 
1Natural folate sources:  spinach folate, 50% polyglutamyl folate;  yeast folate, 100% 
polyglutamyl folate. 
 
 
 
 
 
 
 
 
 
